Gentamicin and Paraplegia - a phase IV clinical study of FDA data

Summary:

Paraplegia is reported as a side effect among people who take Gentamicin (gentamicin sulfate), especially for people who are male, 20-29 old, also take Heparin, and have Myocarditis.

The phase IV clinical study analyzes which people have Paraplegia when taking Gentamicin. It is created by eHealthMe based on reports of 21,523 people who have side effects when taking Gentamicin from the FDA, and is updated regularly.

What is Gentamicin?

Gentamicin has active ingredients of gentamicin sulfate. It is often used in urinary tract infection. eHealthMe is studying from 21,654 Gentamicin users. Check the latest studies of Gentamicin.

What is Paraplegia?

Paraplegia (paralysis of the legs and lower body) is found to be associated with 435 drugs and 537 conditions by eHealthMe. Check the latest studies of Paraplegia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

21,523 people reported to have side effects when taking Gentamicin.
Among them, 23 people (0.11%) have Paraplegia.

Among these 23 people:

What is the gender of people who have Paraplegia when taking Gentamicin? *

female: 40.91 %
male: 59.09 %

What is the age of people who have Paraplegia when taking Gentamicin? *

What are other drugs people take besides Gentamicin? *

What are other side effects people have besides Paraplegia? *

Oedema Peripheral (superficial swelling): 11 people, 47.83%
Back Pain: 10 people, 43.48%
Fever: 9 people, 39.13%
Stress And Anxiety: 9 people, 39.13%
Weight Decreased: 9 people, 39.13%
Weakness: 9 people, 39.13%
Gallstones (stone formation by bile component): 9 people, 39.13%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 9 people, 39.13%
Hypokalemia (low potassium): 9 people, 39.13%
Drug Withdrawal Syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation): 9 people, 39.13%

What are the existing conditions these people have? *

Myocarditis (inflammation of heart muscle myocardium): 4 people, 17.39%
Muscle Spasms (muscle contraction): 3 people, 13.04%
Laxative Supportive Care: 3 people, 13.04%
Drowsiness: 3 people, 13.04%
Constipation: 3 people, 13.04%
Bacteraemia (presence of bacteria in the blood): 2 people, 8.70%
Acute Coronary Syndrome (acute chest pain and other symptoms that happen because the heart does not get blood): 2 people, 8.70%
Staphylococcal Infection (an infection with staphylococcus bacteria): 1 person, 4.35%
Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 4.35%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Gentamicin and have Paraplegia?

- Check whether Paraplegia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gentamicin:

Gentamicin (21,654 reports)

Paraplegia treatments and more:

Paraplegia (3,983 reports)

Browse all side effects of Gentamicin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Paraplegia:

Paraplegia (435 drugs)

Browse all the conditions that are associated with Paraplegia:

Paraplegia (537 conditions)

Related publications that referenced our studies

Lee, Y. J., & Park, K. , "Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension", Drug safety-case reports, 2018 Jan .
Lee, Y. J., & Park, K. , "Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension", Drug safety-case reports, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on gentamicin sulfate (the active ingredients of Gentamicin) and Gentamicin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.